Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20409)

• Formulation Name: Spironolactone 25 mg tablet
• Company: NCS HealthCare of KY, Inc dba Vangard Labs

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Spironolactone	(DM2AQ5N)	Chronic heart failure	BD1Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Calcium sulfate dihydrate	(E00315)	24928	Desiccant; Diluent
Carmellose sodium	(E00625)	Not Available	Disintegrant
Crospovidone	(E00626)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent